FLEMINGTON PHARMACEUTICAL CORP
10QSB, EX-27, 2000-12-14
PHARMACEUTICAL PREPARATIONS
Previous: FLEMINGTON PHARMACEUTICAL CORP, 10QSB, EX-11, 2000-12-14
Next: AMB PROPERTY CORP, 8-K/A, 2000-12-14



<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     (Replace this text with the legend)
</LEGEND>
<CIK>                         0001043873
<NAME>                        FLEMINGTON PHARMACEUTICAL CORPORATION
<MULTIPLIER>                  1,000
<CURRENCY>                    USSD

<S>                                  <C>
<PERIOD-TYPE>                              3-MOS
<FISCAL-YEAR-END>                    JUL-31-2001
<PERIOD-START>                       AUG-01-2000
<PERIOD-END>                         OCT-31-2000
<EXCHANGE-RATE>                            1,000
<CASH>                                       215
<SECURITIES>                                   0
<RECEIVABLES>                                 48
<ALLOWANCES>                                  15
<INVENTORY>                                    0
<CURRENT-ASSETS>                             386
<PP&E>                                        50
<DEPRECIATION>                                 0
<TOTAL-ASSETS>                               590
<CURRENT-LIABILITIES>                         94
<BONDS>                                        0
                          0
                                    0
<COMMON>                                       6
<OTHER-SE>                                   490
<TOTAL-LIABILITY-AND-EQUITY>                 590
<SALES>                                       65
<TOTAL-REVENUES>                              75
<CGS>                                          0
<TOTAL-COSTS>                                427
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             0
<INCOME-PRETAX>                             (352)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                         (352)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                (352)
<EPS-BASIC>                                 (.06)
<EPS-DILUTED>                               (.06)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission